Turgencin B

General Information


DRACP ID  DRACP00939

Peptide Name   Turgencin B

Sequence  GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG

Sequence Length  35

UniProt ID  Not available

PubChem CID  Not available

Origin  Synoicum turgens

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A2058 Amelanotic melanoma Carcinoma IC50=4.1 µM AqueousOne assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  MRC-5: IC50=7.5 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00939

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys7<--->Cys31; Cys11<--->Cys27; Cys16<--->Cys24

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C143H248N42O46S8

Absent amino acids  FHRWY

Common amino acids  C

Mass  415497

Pl  8.11

Basic residues  4

Acidic residues  2

Hydrophobic residues  10

Net charge  2

Boman Index  -1508

Hydrophobicity  26.86

Aliphatic Index  67.14

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  375

Absorbance 280nm  11.03

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31940927

Title  Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens

Doi 10.3390/md18010051

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.